Press release
Theranostics Market Set to Revolutionize Personalized Medicine with Breakthroughs in Targeted Diagnosis and Therapy 2025 | Top key players - GE Healthcare, Jubilant Pharmova Limited, Theragnostics Ltd.
Theranostics Market
The Theranostics Market, as analyzed by DataM Intelligence, offers a comprehensive industry overview backed by in-depth insights, historical trends, and key statistics. The report dives deep into market dynamics and competitive strategies, profiling major players along with their product portfolios, pricing models, financial performance, growth initiatives, and regional presence.
Unlock Exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/theranostics-market?sz
The Theranostics Market refers to the integrated approach of combining diagnostics and therapeutics to personalize patient care, especially in oncology. This market focuses on using specific diagnostic tests to determine the most effective treatment options for individuals. It enables targeted therapy, improves treatment outcomes, and reduces side effects by tailoring interventions based on a patient's unique disease profile.
Major players in the Theranostics market
The prominent players in Theranostics market research report are: GE Healthcare, Jubilant Pharmova Limited (Jubilant Pharma Limited), Theragnostics Ltd., NuView Life Sciences, Lantheus Holdings, Inc., CapVest Limited (Curium Pharma), Clarity Pharmaceuticals, Cardinal Health, LLC, Advanced Accelerator Applications, and ITM Isotopen Technologien München AG among others.
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In February 2022, Theragnostics achieved two significant regulatory milestones. On February 22, the company announced that its radiodiagnostic imaging agent NephroScan received FDA Marketing Approval for evaluating renal parenchymal disorders in adult and pediatric patients, including term neonates.
On February 10, Theragnostics revealed that its investigational agent I-123 PARPi (THG-009) had been granted an Innovation Passport by the UK MHRA under the Innovative Licensing and Access Pathway (ILAP). This designation supports accelerated development of the therapy for treating primary and recurrent Glioblastoma Multiforme (GBM).
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/theranostics-market
Market Segments
By Application: Oncology, Neurological Disorder, Cardiovascular Disease and Others.
By Radioisotopes: Technetium-99, Gallium-68, Lutetium (Lu) 177, Iodine-131, Zirconium-89 , Y-90 and Others.
By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers and Others.
The Theranostics industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Theranostics Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Theranostics Market Set to Revolutionize Personalized Medicine with Breakthroughs in Targeted Diagnosis and Therapy 2025 | Top key players - GE Healthcare, Jubilant Pharmova Limited, Theragnostics Ltd. here
News-ID: 4054571 • Views: …
More Releases from DataM Intelligence 4Market Research
Global Basal Cell Carcinoma Treatment Market Set to Soar with Innovative Therapi …
Market Overview:
The Global Basal Cell Carcinoma Treatment Market is expected to grow at a CAGR of 9.4% during the forecast period 2024-2031.
The Basal Cell Carcinoma Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Basal Cell Carcinoma Treatment market…
Weight Loss Therapeutics Market is Estimated to Advance at a CAGR of 20.6%, reac …
Market Size and Growth:
The Global Weight Loss Therapeutics Market Size reached US$ 3.92 Billion in 2024 and is expected to reach US$ 20.84 Billion by 2033, growing at a CAGR of 20.6% during the forecast period 2025-2033.
The Weight Loss Therapeutics Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
Interventional Oncology Devices Market Set to Surge with Breakthrough Cancer The …
Market Size and Growth:
The Global Interventional Oncology Devices Market Size reached US$ 2.70 Billion in 2024 and is expected to reach US$ 5.00 Billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033.
The Interventional Oncology Devices Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
Hemophilia Market Surges as Gene Therapy and Novel Biologics Transform Patient O …
Market Size and Growth:
The Hemophilia Market reached US$ 13.03 Billion in 2024 and is expected to reach US$ 21.82 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.
The Hemophilia Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these…
More Releases for Theranostics
Theranostics Market in 2025 Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Theranostics Market -(Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Theranostics Market Size is valued…
Rising Cancer Prevalence Fuels Growth In The Theranostics Market Driver: Leading …
What combination of drivers is leading to accelerated growth in the theranostics market?
The theranostics market is forecasted to grow due to an upward trend in cancer cases. Cancer, a disease characterized by unchecked cell growth affecting numerous organs, is a leading cause of considerable illness and death globally. Theranostics, combining therapeutic and diagnostic aspects, holds significant prospects in managing cancer and chronic illnesses. This methodology paves the way for tailored…
Theranostics Market worth $4.3 billion by 2028
The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall theranostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies.
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3…
Theranostics Market Worth $4.3 Billion | MarketsandMarkets Trademark
Theranostics Market in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028
Theranostics Market [https://www.marketsandmarkets.com/Market-Reports/theranostics-market-111696976.html?utm_source=Prnewswire&utm_medium=referral&utm_campaign=paidpr] in terms of revenue was estimated to be worth $2.1 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 15.5% from 2023 to 2028 according to…
Theranostics Market: Pioneering Precision Medicine into 2030
The Theranostics Market was valued USD 1.9 Billion in 2023 and projected to reach USD 5.4 Billion by 2030, growing at a CAGR of 16.2% during the forecast period of 2024-2030.
The Theranostics Market report studies the competitive environment of the Theranostics Market based on company profiles and their efforts to increase product value and production. The Theranostics Market report discusses various factors driving or restraining the market, which will help…
Theranostics Market Is Booming Worldwide Just Published
Global Theranostics Market: An Overview
Theranostics is a new field of medicine which relies on targeted therapies to conduct specific targeted tests. These tests are mainly used for various forms of cancers. The key concern in the therapeutics involve patient centric care with the help of more personalised and precise approach. The technique relies on the use of diagnostic and therapeutic applications to form a single agent. The system is known…
